WeVote
Log In

Bill

Bill

LB 1132

Require the Department of Health and Human Services to file a state plan amendment for coverage of long-acting injectable and extended-release medications for certain individuals

109th Legislature (2025-2026) Introduced by John Fredrickson

LB 1132 mandates Nebraska pursue federal Medicaid approval to cover long-acting injectable and extended-release medications for specified beneficiary populations, improving treatment adherence but increasing program costs.

Notice of hearing for February 11, 2026
0
WeVote Research Nonpartisan
Bill Summary · LB 1132

Legislative bill overview

LB 1132 requires Nebraska's Department of Health and Human Services to file a state plan amendment with the federal government to expand Medicaid coverage for long-acting injectable and extended-release medications for specified populations. The bill mandates that DHHS pursue this coverage expansion through the existing Medicaid state plan process, which allows states to modify their federal-approved healthcare programs.

Why is this important

Long-acting injectable and extended-release medications can improve treatment adherence and health outcomes for individuals managing chronic conditions or mental health disorders, but cost often limits access for low-income populations. This bill directly affects Medicaid beneficiaries' ability to access potentially more effective medication formulations, while also requiring the state to justify the expansion's costs and benefits to federal regulators. The state plan amendment process means any coverage expansion would be subject to federal approval and ongoing compliance requirements.

Potential points of contention

  • Medicaid budget impact: Expanding medication coverage increases state and federal spending; opponents may question cost-effectiveness versus traditional formulations, while supporters argue better adherence reduces overall healthcare costs
  • Definition ambiguity: The bill's reference to "certain individuals" lacks specificity about which diagnoses, age groups, or conditions qualify, creating implementation challenges and potential coverage disputes
  • Federal approval uncertainty: State plan amendments face federal review; there's no guarantee CMS will approve the requested expansion, making the mandate's achievability unclear

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.